Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZBTB33
|
ENSG00000177485.6 | zinc finger and BTB domain containing 33 |
CHD2
|
ENSG00000173575.14 | chromodomain helicase DNA binding protein 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_93426669_93427240 | CHD2 | 428 | 0.830658 | 0.95 | 1.0e-04 | Click! |
chr15_93444315_93444914 | CHD2 | 1049 | 0.507233 | 0.94 | 1.8e-04 | Click! |
chr15_93427420_93428173 | CHD2 | 1270 | 0.446667 | 0.91 | 6.5e-04 | Click! |
chr15_93447757_93448654 | CHD2 | 502 | 0.505626 | 0.90 | 8.9e-04 | Click! |
chr15_93427252_93427403 | CHD2 | 801 | 0.625443 | 0.89 | 1.1e-03 | Click! |
chrX_119384747_119385998 | ZBTB33 | 762 | 0.686451 | 0.94 | 1.4e-04 | Click! |
chrX_119378286_119379238 | ZBTB33 | 5845 | 0.227009 | 0.94 | 1.8e-04 | Click! |
chrX_119384195_119384505 | ZBTB33 | 257 | 0.930695 | 0.65 | 6.0e-02 | Click! |
chrX_119378020_119378209 | ZBTB33 | 6493 | 0.222743 | 0.40 | 2.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_677442_677606 | 2.24 |
TMEM18 |
transmembrane protein 18 |
85 |
0.8 |
chr15_65185686_65185837 | 2.07 |
ENSG00000264929 |
. |
6677 |
0.16 |
chr9_6413115_6413266 | 1.83 |
UHRF2 |
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase |
133 |
0.97 |
chr13_115047037_115047250 | 1.71 |
UPF3A |
UPF3 regulator of nonsense transcripts homolog A (yeast) |
40 |
0.97 |
chr19_4402510_4402661 | 1.65 |
CHAF1A |
chromatin assembly factor 1, subunit A (p150) |
74 |
0.93 |
chr7_134671218_134671514 | 1.64 |
AGBL3 |
ATP/GTP binding protein-like 3 |
85 |
0.98 |
chr21_34638791_34639068 | 1.62 |
IL10RB |
interleukin 10 receptor, beta |
266 |
0.58 |
chrX_154012446_154012633 | 1.62 |
ENSG00000206693 |
. |
9266 |
0.12 |
chr10_106028977_106029146 | 1.60 |
GSTO2 |
glutathione S-transferase omega 2 |
122 |
0.9 |
chr11_109964090_109964241 | 1.52 |
ZC3H12C |
zinc finger CCCH-type containing 12C |
78 |
0.99 |
chr5_139493535_139493731 | 1.51 |
PURA |
purine-rich element binding protein A |
75 |
0.96 |
chr1_147624641_147624792 | 1.51 |
BX842679.1 |
Uncharacterized protein FLJ46360 |
7712 |
0.19 |
chr1_26146477_26146913 | 1.48 |
MTFR1L |
mitochondrial fission regulator 1-like |
11 |
0.82 |
chr17_16116868_16117019 | 1.47 |
NCOR1 |
nuclear receptor corepressor 1 |
1900 |
0.27 |
chr12_54019958_54020201 | 1.46 |
ATF7 |
activating transcription factor 7 |
68 |
0.8 |
chr9_26955840_26956348 | 1.44 |
RP11-337A23.3 |
|
199 |
0.59 |
chr2_203130282_203130433 | 1.39 |
NOP58 |
NOP58 ribonucleoprotein |
82 |
0.95 |
chr4_186064341_186064625 | 1.38 |
SLC25A4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
88 |
0.97 |
chrX_19905965_19906127 | 1.35 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
327 |
0.92 |
chr9_125667571_125667722 | 1.33 |
RC3H2 |
ring finger and CCCH-type domains 2 |
26 |
0.96 |
chr17_18965457_18965608 | 1.32 |
ENSG00000265185 |
. |
307 |
0.8 |
chr1_10753895_10754065 | 1.29 |
CASZ1 |
castor zinc finger 1 |
48847 |
0.13 |
chr1_104068375_104068584 | 1.29 |
RNPC3 |
RNA-binding region (RNP1, RRM) containing 3 |
100 |
0.8 |
chr16_2390604_2390763 | 1.28 |
ABCA3 |
ATP-binding cassette, sub-family A (ABC1), member 3 |
53 |
0.95 |
chr12_57940971_57941264 | 1.25 |
DCTN2 |
dynactin 2 (p50) |
3 |
0.94 |
chr6_44355057_44355355 | 1.25 |
CDC5L |
cell division cycle 5-like |
56 |
0.97 |
chr2_85554987_85555138 | 1.24 |
TGOLN2 |
trans-golgi network protein 2 |
46 |
0.95 |
chr2_159313710_159313861 | 1.23 |
PKP4 |
plakophilin 4 |
161 |
0.83 |
chr3_125314189_125314340 | 1.23 |
OSBPL11 |
oxysterol binding protein-like 11 |
330 |
0.9 |
chr1_207226273_207226577 | 1.22 |
YOD1 |
YOD1 deubiquitinase |
100 |
0.61 |
chr16_2015338_2015613 | 1.22 |
ENSG00000255198 |
. |
290 |
0.55 |
chr16_85932806_85932957 | 1.21 |
IRF8 |
interferon regulatory factor 8 |
112 |
0.97 |
chr4_178363635_178364106 | 1.20 |
AGA |
aspartylglucosaminidase |
213 |
0.92 |
chr7_158766053_158766279 | 1.20 |
ENSG00000231419 |
. |
34946 |
0.21 |
chr19_49999188_49999461 | 1.18 |
RPS11 |
ribosomal protein S11 |
307 |
0.65 |
chr6_100016616_100016961 | 1.16 |
CCNC |
cyclin C |
61 |
0.93 |
chr1_146082792_146082943 | 1.15 |
NBPF11 |
neuroblastoma breakpoint family, member 11 |
102 |
0.97 |
chr1_151763883_151764063 | 1.14 |
TDRKH |
tudor and KH domain containing |
81 |
0.87 |
chr1_231473805_231474036 | 1.14 |
SPRTN |
SprT-like N-terminal domain |
82 |
0.79 |
chr7_23571303_23571524 | 1.13 |
TRA2A |
transformer 2 alpha homolog (Drosophila) |
182 |
0.95 |
chr11_44087850_44088076 | 1.13 |
ACCS |
1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional) |
88 |
0.96 |
chr19_54704710_54704936 | 1.12 |
RPS9 |
ribosomal protein S9 |
81 |
0.9 |
chr9_98637907_98638174 | 1.11 |
ERCC6L2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6-like 2 |
57 |
0.98 |
chr11_315733_315898 | 1.11 |
IFITM1 |
interferon induced transmembrane protein 1 |
1962 |
0.12 |
chr1_36023479_36023699 | 1.10 |
NCDN |
neurochondrin |
180 |
0.68 |
chr11_64009123_64009509 | 1.10 |
FKBP2 |
FK506 binding protein 2, 13kDa |
96 |
0.89 |
chr5_170814799_170815118 | 1.10 |
NPM1 |
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
73 |
0.95 |
chr9_98079727_98079955 | 1.10 |
FANCC |
Fanconi anemia, complementation group C |
143 |
0.97 |
chr14_61447467_61447742 | 1.08 |
TRMT5 |
tRNA methyltransferase 5 |
165 |
0.59 |
chr1_110881517_110881734 | 1.07 |
RP5-1074L1.1 |
|
168 |
0.68 |
chr14_50359928_50360163 | 1.07 |
ARF6 |
ADP-ribosylation factor 6 |
235 |
0.89 |
chr6_149639180_149639378 | 1.07 |
TAB2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
157 |
0.96 |
chrX_53710808_53711038 | 1.06 |
HUWE1 |
HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase |
191 |
0.97 |
chr14_90084669_90085459 | 1.06 |
FOXN3 |
forkhead box N3 |
410 |
0.78 |
chr10_102820502_102820742 | 1.03 |
KAZALD1 |
Kazal-type serine peptidase inhibitor domain 1 |
976 |
0.42 |
chr6_25279280_25279483 | 1.02 |
LRRC16A |
leucine rich repeat containing 16A |
275 |
0.9 |
chr6_134273516_134273821 | 0.99 |
TBPL1 |
TBP-like 1 |
244 |
0.95 |
chr7_99775462_99775676 | 0.99 |
STAG3 |
stromal antigen 3 |
10 |
0.88 |
chr11_95976608_95976814 | 0.96 |
ENSG00000266192 |
. |
97891 |
0.08 |
chr8_37963037_37963244 | 0.96 |
ASH2L |
ash2 (absent, small, or homeotic)-like (Drosophila) |
72 |
0.95 |
chr17_40713940_40714106 | 0.95 |
COASY |
CoA synthase |
69 |
0.93 |
chr9_100954385_100954647 | 0.94 |
CORO2A |
coronin, actin binding protein, 2A |
406 |
0.87 |
chr19_1438420_1438608 | 0.94 |
RPS15 |
ribosomal protein S15 |
95 |
0.9 |
chr2_149402275_149402426 | 0.94 |
EPC2 |
enhancer of polycomb homolog 2 (Drosophila) |
203 |
0.97 |
chr2_65217569_65217720 | 0.94 |
SLC1A4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
1109 |
0.46 |
chr22_41864731_41865006 | 0.93 |
PHF5A |
PHD finger protein 5A |
139 |
0.66 |
chr16_70148022_70148173 | 0.93 |
PDPR |
pyruvate dehydrogenase phosphatase regulatory subunit |
178 |
0.94 |
chr4_48781544_48781758 | 0.93 |
FRYL |
FRY-like |
614 |
0.77 |
chr4_170540985_170541480 | 0.93 |
CLCN3 |
chloride channel, voltage-sensitive 3 |
440 |
0.86 |
chr14_92980994_92981252 | 0.92 |
RIN3 |
Ras and Rab interactor 3 |
975 |
0.68 |
chr8_42249064_42249291 | 0.91 |
VDAC3 |
voltage-dependent anion channel 3 |
35 |
0.97 |
chr1_100315284_100315645 | 0.91 |
AGL |
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
176 |
0.95 |
chr20_25834307_25834485 | 0.91 |
FAM182B |
family with sequence similarity 182, member B |
7817 |
0.28 |
chr3_52567337_52567575 | 0.91 |
NT5DC2 |
5'-nucleotidase domain containing 2 |
91 |
0.94 |
chr3_101232172_101232547 | 0.91 |
SENP7 |
SUMO1/sentrin specific peptidase 7 |
274 |
0.9 |
chr17_19093169_19093320 | 0.90 |
ENSG00000264940 |
. |
314 |
0.77 |
chr19_44488599_44488754 | 0.89 |
ZNF155 |
zinc finger protein 155 |
303 |
0.82 |
chr13_36919693_36920223 | 0.89 |
SPG20 |
spastic paraplegia 20 (Troyer syndrome) |
462 |
0.53 |
chr19_13213099_13213611 | 0.89 |
LYL1 |
lymphoblastic leukemia derived sequence 1 |
326 |
0.79 |
chr2_191184295_191184614 | 0.89 |
HIBCH |
3-hydroxyisobutyryl-CoA hydrolase |
162 |
0.96 |
chr7_35734529_35734726 | 0.89 |
HERPUD2 |
HERPUD family member 2 |
6 |
0.72 |
chr10_51565162_51565492 | 0.88 |
NCOA4 |
nuclear receptor coactivator 4 |
97 |
0.97 |
chr3_42641972_42642375 | 0.88 |
NKTR |
natural killer-tumor recognition sequence |
62 |
0.63 |
chr5_149380800_149381041 | 0.88 |
TIGD6 |
tigger transposable element derived 6 |
190 |
0.82 |
chr6_143266637_143266831 | 0.88 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
396 |
0.9 |
chr12_118407162_118407341 | 0.87 |
KSR2 |
kinase suppressor of ras 2 |
463 |
0.85 |
chr9_129988106_129988257 | 0.87 |
GARNL3 |
GTPase activating Rap/RanGAP domain-like 3 |
663 |
0.67 |
chr13_79980140_79980404 | 0.87 |
RBM26 |
RNA binding motif protein 26 |
78 |
0.64 |
chr14_20923431_20923659 | 0.87 |
APEX1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
121 |
0.68 |
chr19_3434872_3435193 | 0.86 |
C19orf77 |
chromosome 19 open reading frame 77 |
43454 |
0.09 |
chr15_66797167_66797489 | 0.86 |
ZWILCH |
zwilch kinetochore protein |
31 |
0.56 |
chr2_17935788_17935956 | 0.86 |
GEN1 |
GEN1 Holliday junction 5' flap endonuclease |
445 |
0.66 |
chr1_244014036_244014266 | 0.84 |
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
230 |
0.95 |
chr1_40254360_40254539 | 0.83 |
BMP8B |
bone morphogenetic protein 8b |
72 |
0.67 |
chr3_93781843_93782253 | 0.83 |
DHFRL1 |
dihydrofolate reductase-like 1 |
19 |
0.8 |
chr21_47517524_47517733 | 0.83 |
AP001471.1 |
|
184 |
0.71 |
chr19_7985242_7985410 | 0.83 |
SNAPC2 |
small nuclear RNA activating complex, polypeptide 2, 45kDa |
54 |
0.9 |
chr2_197664188_197664418 | 0.83 |
GTF3C3 |
general transcription factor IIIC, polypeptide 3, 102kDa |
80 |
0.97 |
chr17_79819005_79819178 | 0.83 |
P4HB |
prolyl 4-hydroxylase, beta polypeptide |
521 |
0.51 |
chr7_152161336_152161564 | 0.83 |
ENSG00000221454 |
. |
25144 |
0.18 |
chr6_43395331_43395565 | 0.82 |
ABCC10 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 10 |
156 |
0.93 |
chr2_110371590_110371807 | 0.82 |
SEPT10 |
septin 10 |
22 |
0.74 |
chr19_12511559_12512039 | 0.82 |
ZNF799 |
zinc finger protein 799 |
5 |
0.96 |
chrX_123096191_123096863 | 0.81 |
STAG2 |
stromal antigen 2 |
493 |
0.85 |
chr1_98386778_98387098 | 0.81 |
DPYD |
dihydropyrimidine dehydrogenase |
333 |
0.94 |
chr10_118608958_118609220 | 0.81 |
ENO4 |
enolase family member 4 |
5 |
0.62 |
chr17_80231729_80231964 | 0.81 |
CSNK1D |
casein kinase 1, delta |
239 |
0.87 |
chr12_6982073_6982438 | 0.81 |
SPSB2 |
splA/ryanodine receptor domain and SOCS box containing 2 |
194 |
0.7 |
chr20_45318051_45318277 | 0.80 |
TP53RK |
TP53 regulating kinase |
85 |
0.97 |
chr19_4124024_4124182 | 0.80 |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
11 |
0.96 |
chr9_125674967_125675313 | 0.79 |
ZBTB6 |
zinc finger and BTB domain containing 6 |
469 |
0.7 |
chr7_149470838_149471041 | 0.79 |
ZNF467 |
zinc finger protein 467 |
371 |
0.88 |
chr17_19015403_19015696 | 0.79 |
ENSG00000262202 |
. |
400 |
0.71 |
chr2_28789922_28790261 | 0.79 |
PLB1 |
phospholipase B1 |
18724 |
0.22 |
chr22_31318038_31318328 | 0.78 |
MORC2-AS1 |
MORC2 antisense RNA 1 |
112 |
0.96 |
chr17_27716871_27717334 | 0.78 |
TAOK1 |
TAO kinase 1 |
380 |
0.47 |
chr16_89883220_89883514 | 0.78 |
FANCA |
Fanconi anemia, complementation group A |
302 |
0.87 |
chr5_175085394_175085606 | 0.78 |
HRH2 |
histamine receptor H2 |
467 |
0.84 |
chr13_52419429_52419580 | 0.78 |
CCDC70 |
coiled-coil domain containing 70 |
16613 |
0.19 |
chr5_175964065_175964400 | 0.77 |
RNF44 |
ring finger protein 44 |
189 |
0.91 |
chr6_127663869_127664220 | 0.77 |
ECHDC1 |
enoyl CoA hydratase domain containing 1 |
24 |
0.98 |
chr5_77071845_77072151 | 0.77 |
TBCA |
tubulin folding cofactor A |
87 |
0.98 |
chr9_136214837_136215096 | 0.76 |
MED22 |
mediator complex subunit 22 |
6 |
0.56 |
chr17_19091594_19091745 | 0.76 |
ENSG00000263934 |
. |
340 |
0.74 |
chr10_75118296_75118543 | 0.76 |
TTC18 |
tetratricopeptide repeat domain 18 |
117 |
0.94 |
chr19_47353649_47354096 | 0.75 |
AP2S1 |
adaptor-related protein complex 2, sigma 1 subunit |
151 |
0.95 |
chr16_30969477_30969628 | 0.75 |
SETD1A |
SET domain containing 1A |
475 |
0.61 |
chr7_27170035_27170414 | 0.74 |
HOXA4 |
homeobox A4 |
128 |
0.82 |
chr10_51622635_51622904 | 0.74 |
TIMM23 |
translocase of inner mitochondrial membrane 23 homolog (yeast) |
434 |
0.83 |
chr5_180645822_180645981 | 0.74 |
TRIM41 |
tripartite motif containing 41 |
3598 |
0.09 |
chr19_639517_639685 | 0.74 |
FGF22 |
fibroblast growth factor 22 |
294 |
0.79 |
chr17_47269954_47270212 | 0.74 |
GNGT2 |
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
16191 |
0.14 |
chr12_51984041_51984192 | 0.74 |
SCN8A |
sodium channel, voltage gated, type VIII, alpha subunit |
594 |
0.82 |
chrY_14774455_14774643 | 0.74 |
USP9Y |
ubiquitin specific peptidase 9, Y-linked |
38611 |
0.22 |
chr4_144434579_144434842 | 0.74 |
SMARCA5 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
94 |
0.95 |
chr17_36858727_36858878 | 0.74 |
ENSG00000265930 |
. |
218 |
0.82 |
chr3_9772457_9772897 | 0.74 |
BRPF1 |
bromodomain and PHD finger containing, 1 |
736 |
0.52 |
chr16_31724890_31725110 | 0.74 |
ZNF720 |
zinc finger protein 720 |
373 |
0.8 |
chr6_7911236_7911479 | 0.74 |
TXNDC5 |
thioredoxin domain containing 5 (endoplasmic reticulum) |
310 |
0.94 |
chr8_98290242_98290499 | 0.73 |
TSPYL5 |
TSPY-like 5 |
194 |
0.97 |
chr4_120133020_120133616 | 0.73 |
RP11-455G16.1 |
Uncharacterized protein |
349 |
0.59 |
chr14_62162303_62162586 | 0.73 |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
51 |
0.98 |
chr8_42911047_42911330 | 0.73 |
FNTA |
farnesyltransferase, CAAX box, alpha |
108 |
0.96 |
chr11_43809952_43810143 | 0.73 |
RP11-613D13.5 |
|
45420 |
0.15 |
chr15_40074828_40075066 | 0.73 |
FSIP1 |
fibrous sheath interacting protein 1 |
84 |
0.63 |
chr9_128592071_128592626 | 0.73 |
PBX3 |
pre-B-cell leukemia homeobox 3 |
35202 |
0.22 |
chr10_104678051_104678263 | 0.73 |
CNNM2 |
cyclin M2 |
43 |
0.97 |
chr2_111877900_111878292 | 0.73 |
BCL2L11 |
BCL2-like 11 (apoptosis facilitator) |
395 |
0.88 |
chr17_53499567_53499852 | 0.73 |
MMD |
monocyte to macrophage differentiation-associated |
356 |
0.93 |
chr20_32951146_32951354 | 0.71 |
ITCH |
itchy E3 ubiquitin protein ligase |
132 |
0.95 |
chr2_214148558_214149019 | 0.71 |
SPAG16 |
sperm associated antigen 16 |
325 |
0.94 |
chrX_80457343_80457513 | 0.71 |
HMGN5 |
high mobility group nucleosome binding domain 5 |
13 |
0.5 |
chr9_137029041_137029227 | 0.71 |
ENSG00000221676 |
. |
552 |
0.77 |
chr14_61448428_61448630 | 0.71 |
SLC38A6 |
solute carrier family 38, member 6 |
367 |
0.55 |
chr7_55432950_55433527 | 0.71 |
LANCL2 |
LanC lantibiotic synthetase component C-like 2 (bacterial) |
97 |
0.98 |
chr5_70882830_70883043 | 0.71 |
MCCC2 |
methylcrotonoyl-CoA carboxylase 2 (beta) |
188 |
0.96 |
chr17_74732673_74732824 | 0.70 |
ENSG00000207556 |
. |
118 |
0.55 |
chr16_24550856_24551187 | 0.70 |
RBBP6 |
retinoblastoma binding protein 6 |
144 |
0.98 |
chr13_100067599_100067750 | 0.70 |
ENSG00000266207 |
. |
38049 |
0.14 |
chr1_167599117_167599313 | 0.70 |
RCSD1 |
RCSD domain containing 1 |
115 |
0.91 |
chr14_69258718_69258869 | 0.69 |
ZFP36L1 |
ZFP36 ring finger protein-like 1 |
833 |
0.67 |
chr7_4722284_4722490 | 0.69 |
FOXK1 |
forkhead box K1 |
447 |
0.84 |
chr20_50807500_50807971 | 0.69 |
ZFP64 |
ZFP64 zinc finger protein |
501 |
0.89 |
chrX_3732446_3732681 | 0.69 |
RP11-706O15.1 |
HCG1981372, isoform CRA_c; Uncharacterized protein |
29335 |
0.23 |
chr5_89704739_89705208 | 0.69 |
CETN3 |
centrin, EF-hand protein, 3 |
576 |
0.77 |
chr5_175788548_175788764 | 0.69 |
KIAA1191 |
KIAA1191 |
108 |
0.93 |
chr16_71929753_71930351 | 0.69 |
IST1 |
increased sodium tolerance 1 homolog (yeast) |
560 |
0.66 |
chr5_179498860_179499156 | 0.69 |
RNF130 |
ring finger protein 130 |
93 |
0.97 |
chr2_111876466_111876617 | 0.69 |
BCL2L11 |
BCL2-like 11 (apoptosis facilitator) |
414 |
0.87 |
chr19_12750863_12751051 | 0.69 |
ENSG00000221343 |
. |
10409 |
0.08 |
chr7_72935956_72936258 | 0.68 |
BAZ1B |
bromodomain adjacent to zinc finger domain, 1B |
495 |
0.75 |
chr11_18033977_18034250 | 0.68 |
SERGEF |
secretion regulating guanine nucleotide exchange factor |
332 |
0.89 |
chr14_102414152_102414349 | 0.68 |
DYNC1H1 |
dynein, cytoplasmic 1, heavy chain 1 |
16615 |
0.19 |
chr14_91862319_91862609 | 0.68 |
CCDC88C |
coiled-coil domain containing 88C |
21226 |
0.21 |
chr6_109415362_109415602 | 0.68 |
SESN1 |
sestrin 1 |
540 |
0.59 |
chr9_21802191_21802384 | 0.67 |
MTAP |
methylthioadenosine phosphorylase |
255 |
0.92 |
chrX_41193058_41193339 | 0.67 |
DDX3X |
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
217 |
0.93 |
chr19_33165911_33166093 | 0.67 |
ANKRD27 |
ankyrin repeat domain 27 (VPS9 domain) |
51 |
0.8 |
chr12_53846194_53846396 | 0.67 |
PCBP2 |
poly(rC) binding protein 2 |
143 |
0.93 |
chr16_28761735_28761940 | 0.67 |
NPIPB9 |
nuclear pore complex interacting protein family, member B9 |
1271 |
0.34 |
chr6_110500546_110500738 | 0.67 |
WASF1 |
WAS protein family, member 1 |
210 |
0.85 |
chr17_55631001_55631152 | 0.67 |
RP11-118E18.2 |
|
30118 |
0.17 |
chr5_134181543_134181694 | 0.67 |
C5orf24 |
chromosome 5 open reading frame 24 |
60 |
0.97 |
chr2_170683881_170684203 | 0.66 |
UBR3 |
ubiquitin protein ligase E3 component n-recognin 3 (putative) |
24 |
0.97 |
chr2_163200130_163200438 | 0.66 |
GCA |
grancalcin, EF-hand calcium binding protein |
314 |
0.92 |
chr5_80690086_80690663 | 0.66 |
ACOT12 |
acyl-CoA thioesterase 12 |
376 |
0.91 |
chrX_67718497_67718882 | 0.66 |
YIPF6 |
Yip1 domain family, member 6 |
205 |
0.96 |
chr10_12237842_12237993 | 0.66 |
CDC123 |
cell division cycle 123 |
47 |
0.49 |
chr6_170124879_170125410 | 0.66 |
RP1-266L20.4 |
|
456 |
0.51 |
chr17_36981334_36981574 | 0.66 |
CWC25 |
CWC25 spliceosome-associated protein homolog (S. cerevisiae) |
114 |
0.85 |
chr12_1552774_1552964 | 0.66 |
ERC1 |
ELKS/RAB6-interacting/CAST family member 1 |
35511 |
0.16 |
chr17_4166415_4167195 | 0.66 |
ANKFY1 |
ankyrin repeat and FYVE domain containing 1 |
337 |
0.88 |
chr2_182757184_182757414 | 0.66 |
SSFA2 |
sperm specific antigen 2 |
376 |
0.76 |
chr1_62902515_62902837 | 0.66 |
USP1 |
ubiquitin specific peptidase 1 |
350 |
0.92 |
chrX_30594869_30596024 | 0.65 |
CXorf21 |
chromosome X open reading frame 21 |
515 |
0.84 |
chr15_44579963_44580499 | 0.65 |
CASC4 |
cancer susceptibility candidate 4 |
696 |
0.76 |
chr5_175815784_175815957 | 0.65 |
NOP16 |
NOP16 nucleolar protein |
106 |
0.51 |
chr16_28375980_28376203 | 0.65 |
NPIPB6 |
nuclear pore complex interacting protein family, member B6 |
1262 |
0.45 |
chr19_3185557_3185759 | 0.65 |
NCLN |
nicalin |
60 |
0.96 |
chr9_44401795_44402070 | 0.65 |
BX088651.1 |
LOC100126582 protein; Uncharacterized protein |
495 |
0.88 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.6 | 2.3 | GO:0015853 | adenine transport(GO:0015853) |
0.5 | 0.5 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.4 | 1.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 1.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 0.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 1.1 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.4 | 1.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.4 | 1.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 1.0 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 0.9 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.3 | 0.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 1.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.8 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.3 | 0.8 | GO:0009301 | snRNA transcription(GO:0009301) |
0.3 | 0.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.7 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 1.7 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.2 | 1.0 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.2 | 0.7 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.2 | 0.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 1.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 1.3 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.2 | 0.6 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 1.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.6 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.2 | 0.8 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.8 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.2 | 1.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 1.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.2 | 0.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 1.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.5 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.2 | 0.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.9 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.2 | 0.5 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.2 | 0.3 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.2 | 0.7 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 0.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.2 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.5 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.8 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.2 | 0.9 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.2 | 0.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.5 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.2 | 0.6 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.9 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.7 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.4 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.1 | 0.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.5 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.5 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.4 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.5 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.4 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 1.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 1.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.2 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.7 | GO:0075713 | establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
0.1 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.6 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.5 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.1 | 0.3 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.1 | 1.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 2.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 2.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.3 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.3 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.1 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 1.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.1 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.2 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.3 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.1 | 0.3 | GO:0061316 | canonical Wnt signaling pathway involved in heart development(GO:0061316) |
0.1 | 0.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 0.9 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.3 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.3 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.3 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.7 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:0016577 | histone demethylation(GO:0016577) |
0.1 | 0.1 | GO:0051322 | anaphase(GO:0051322) |
0.1 | 0.4 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.7 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.2 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.3 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.2 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.8 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) negative regulation of nuclear division(GO:0051784) |
0.1 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 1.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.8 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.2 | GO:0002832 | negative regulation of response to biotic stimulus(GO:0002832) |
0.1 | 2.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.3 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 1.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.5 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 1.5 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.5 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 1.0 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 0.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.4 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.1 | 1.1 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.4 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.4 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.2 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 0.6 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.4 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.4 | GO:0043302 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.1 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.1 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.3 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.5 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.2 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.1 | 11.6 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.3 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 1.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.3 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 1.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 2.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.1 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.3 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 1.1 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.2 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.2 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.2 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.3 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.2 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.8 | GO:0007098 | centrosome cycle(GO:0007098) |
0.1 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 3.7 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.4 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 1.4 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.3 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.1 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 1.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 1.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 1.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.0 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 1.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.0 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.1 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.0 | 0.7 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 9.2 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.0 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 1.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.2 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.9 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.7 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
0.0 | 0.1 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.8 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.0 | 0.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 1.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.1 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.0 | 0.1 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.0 | 0.2 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.4 | GO:0048194 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0046385 | 2'-deoxyribonucleotide biosynthetic process(GO:0009265) deoxyribose phosphate biosynthetic process(GO:0046385) |
0.0 | 0.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 1.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.2 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.1 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.0 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.5 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.5 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) histone lysine methylation(GO:0034968) |
0.0 | 0.6 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.0 | 2.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.3 | GO:0034080 | DNA replication-independent nucleosome assembly(GO:0006336) CENP-A containing nucleosome assembly(GO:0034080) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.5 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.0 | 0.5 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.0 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.1 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.1 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.2 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 2.8 | GO:0019083 | viral gene expression(GO:0019080) viral transcription(GO:0019083) |
0.0 | 0.5 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0033238 | regulation of cellular amino acid metabolic process(GO:0006521) regulation of cellular amine metabolic process(GO:0033238) |
0.0 | 0.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.1 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.0 | 0.0 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.2 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.5 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.2 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0010972 | mitotic G2 DNA damage checkpoint(GO:0007095) negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) mitotic G2/M transition checkpoint(GO:0044818) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.5 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.0 | 0.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 1.4 | GO:0043038 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
0.0 | 0.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.0 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 1.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.2 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.7 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.1 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.0 | 1.0 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.2 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 1.2 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 2.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.1 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.0 | 0.2 | GO:0046036 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
0.0 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 1.5 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.0 | 0.1 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.6 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.0 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.0 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.2 | GO:0042559 | folic acid-containing compound biosynthetic process(GO:0009396) pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.9 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.3 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 2.4 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.2 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0034134 | toll-like receptor 1 signaling pathway(GO:0034130) toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.0 | GO:1901991 | negative regulation of cell cycle phase transition(GO:1901988) negative regulation of mitotic cell cycle phase transition(GO:1901991) negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.3 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.1 | GO:0016571 | histone methylation(GO:0016571) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0090398 | cellular senescence(GO:0090398) |
0.0 | 0.2 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 1.0 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.0 | GO:0034250 | positive regulation of cellular amide metabolic process(GO:0034250) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.2 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.0 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.4 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.0 | GO:0002312 | B cell activation involved in immune response(GO:0002312) |
0.0 | 0.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.4 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.0 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.0 | 3.0 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.0 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.2 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.1 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.0 | GO:0031223 | auditory behavior(GO:0031223) |
0.0 | 0.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.1 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.5 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.0 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.7 | GO:0006165 | glycolytic process(GO:0006096) nucleoside diphosphate phosphorylation(GO:0006165) ATP generation from ADP(GO:0006757) nucleotide phosphorylation(GO:0046939) |
0.0 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.0 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.1 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.0 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.8 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.3 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.0 | 0.2 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.0 | 0.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.0 | 0.1 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.3 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.1 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0002524 | hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) positive regulation of hypersensitivity(GO:0002885) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.2 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.0 | 0.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.0 | 0.1 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
0.0 | 0.4 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.0 | 2.7 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.4 | GO:0042384 | cilium assembly(GO:0042384) |
0.0 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.2 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 1.6 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.2 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.7 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.2 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.0 | 0.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.0 | GO:1903725 | regulation of phospholipid metabolic process(GO:1903725) |
0.0 | 0.0 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.0 | GO:1903050 | regulation of proteolysis involved in cellular protein catabolic process(GO:1903050) |
0.0 | 0.1 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.0 | GO:0045617 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.1 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.0 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) regulation of meiotic cell cycle(GO:0051445) |
0.0 | 0.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0000279 | M phase(GO:0000279) |
0.0 | 0.1 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.3 | GO:0006101 | tricarboxylic acid cycle(GO:0006099) citrate metabolic process(GO:0006101) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.3 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:0046668 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.0 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.0 | 0.1 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.3 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.2 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.0 | 1.3 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.0 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.3 | GO:0070585 | protein localization to mitochondrion(GO:0070585) establishment of protein localization to mitochondrion(GO:0072655) |
0.0 | 0.1 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.1 | GO:0046638 | positive regulation of alpha-beta T cell differentiation(GO:0046638) |
0.0 | 0.1 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.0 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.1 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.0 | 0.1 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.0 | 0.0 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.1 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.0 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
0.0 | 0.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.5 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 0.1 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.1 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.2 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.0 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.0 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.1 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.0 | 0.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.0 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) |
0.0 | 0.0 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.0 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.0 | 0.1 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 2.2 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.2 | 1.1 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 1.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 1.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 1.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 1.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.2 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.1 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.7 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 1.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.1 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 0.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.4 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 0.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.6 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 3.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 1.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 8.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.7 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 1.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 5.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 1.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.2 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.3 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.3 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.4 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.8 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.1 | 0.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 1.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 2.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 2.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 1.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.3 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 1.1 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.0 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 4.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 1.7 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 2.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 1.3 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 5.6 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 1.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.0 | 1.2 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.2 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.0 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.7 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 0.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 1.8 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 6.2 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 1.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 1.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 5.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 1.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.0 | GO:0043189 | H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 3.9 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.4 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 2.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.4 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.6 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 9.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 19.3 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.4 | GO:0044448 | cell cortex part(GO:0044448) |
0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.2 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) anaphase-promoting complex(GO:0005680) |
0.0 | 0.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 1.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.0 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.0 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 4.6 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 1.1 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.8 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.0 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 13.5 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.7 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 7.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.3 | GO:0031983 | platelet alpha granule lumen(GO:0031093) vesicle lumen(GO:0031983) secretory granule lumen(GO:0034774) |
0.0 | 0.0 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.3 | 1.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.3 | 1.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 1.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.3 | 1.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 1.3 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.2 | 0.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.9 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 1.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 1.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 0.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 1.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.8 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.2 | 1.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 0.8 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.7 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.9 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.5 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.2 | 1.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 0.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 0.5 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 2.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.9 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.5 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.5 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.1 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.5 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.5 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 2.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 1.4 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 1.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.4 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 1.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.7 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.9 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 1.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.6 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.4 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.3 | GO:0008443 | 6-phosphofructokinase activity(GO:0003872) phosphofructokinase activity(GO:0008443) |
0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 1.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.1 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 2.3 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.7 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.9 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 1.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 1.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 1.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.7 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.3 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 1.4 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.2 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.6 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 3.3 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.5 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.9 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.6 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 2.9 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 1.7 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 2.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 5.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 4.3 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 3.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 1.1 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0031267 | small GTPase binding(GO:0031267) |
0.0 | 0.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 4.6 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 3.7 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.9 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 1.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.7 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.2 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.4 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.2 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.3 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.8 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 1.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.8 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 4.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 2.0 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 10.4 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.0 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 1.1 | GO:0042626 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) ATPase activity, coupled to transmembrane movement of substances(GO:0042626) ATPase activity, coupled to movement of substances(GO:0043492) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 1.0 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.0 | 0.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 1.2 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 1.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.3 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 1.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0046980 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) tapasin binding(GO:0046980) |
0.0 | 0.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.4 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 1.4 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.0 | 0.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.0 | 0.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 17.6 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.0 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 4.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 4.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 4.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.8 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.9 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.4 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 2.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.1 | 3.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 5.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 2.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.8 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 5.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 2.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 6.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 4.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 5.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.4 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 1.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 2.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 1.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 1.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 2.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 1.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 1.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 2.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 2.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 1.1 | REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION | Genes involved in TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
0.0 | 0.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.1 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 4.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.1 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.3 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |